ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyAllschwilT3 Pharmaceuticals AG
T3 Pharmaceuticals AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of T3 Pharmaceuticals AG is the development of anti-cancer drugs, particularly through the research and development of innovative therapeutics based on microbial pathogenesis and immunotherapy. The company focuses on the discovery and development of new active substances (NCEs) and the clinical development of targeted therapeutics, especially in the fields of oncology and hematology.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

T3 Pharmaceuticals AG

✓ Offered2
Cancer immunotherapy platform with live bacteria
Cancer immunotherapy based on genetically modified live bacteria that specifically colonise solid tumors and deliver selected protein payloads into cells.
Oncology drug-development pipeline
Pipeline based on the platform technology with clinical development, including the lead asset T3P-Y058-739 to trigger a specific immune response in solid tumors.
Trust & reputation

ranQ Trust Score of T3 Pharmaceuticals AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of November 2026

Without public customer reviews the score stays capped.

T3 Pharmaceuticals AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
T3 Pharmaceuticals AG scores 84.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.89.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
T3 Pharmaceuticals AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
T3 Pharmaceuticals AG scores 53.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.77.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.30.04%
Qualifications+0.00

T3 Pharmaceuticals AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

May 21, 2025Media
T3 Pharmaceuticals Blaser Architekten
world-architects.com
November 22, 2023Media
Boehringer Ingelheim acquires T3 Pharma for up to CHF450 million
startupticker.ch
September 3, 2021Media
Fünf Unternehmerinnen und Unternehmer am SEF 2021 ausgezeichnet
netzwoche.ch
June 10, 2021Media
Die Finalisten des Swiss Economic Award stehen fest
startupticker.ch

Knowledge

No knowledge articles yet

Once T3 Pharmaceuticals AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

T3 Pharmaceuticals AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank T3 Pharmaceuticals AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of T3 Pharmaceuticals AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hegenheimermattweg 167A
4123 Allschwil

At a glance

Legal form
Corporation
UID
CHE-176.288.242
Founded
2015 · 11 years
Last commercial register change
May 5, 2025
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    CT
    CAPTOR THERAPEUTICS GmbH
    Allschwil
    CG
    Cancentus GmbH
    Allschwil
    GG
    Gubra GmbH
    Allschwil
    BP
    Basilea Pharmaceutica AG, Allschwil
    Allschwil
    MG
    MiHKAL GmbH
    Allschwil
    NS
    Neurocrine Switzerland GmbH
    Allschwil
    MP
    Merz Pharma (Schweiz) AG
    Allschwil
    IA
    Iscador AG
    Arlesheim